Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2025-12-25 @ 2:05 AM
NCT ID:
NCT05604560
Brief Title:
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
Official Title:
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
Study:
NCT05604560
Protocol Section:
NCT05604560